Holographic Optogenetics Puts Beating Heart Cells Under Light-Based Closed-Loop Control

For decades, cardiologists and bioengineers have dreamed of a way to steer the electrical activity of heart cells with the same precision that an engineer steers a drone: sensing what the system is doing in real time, computing a correction, and applying it instantly. A study published in Communications Engineering now brings that vision substantially closer, demonstrating an all-optical closed-loop control system for human cardiomyocyte networks. The approach combines holographic optogenetics, high-speed optical readout of cellular electrical activity, and real-time feedback algorithms to regulate the beating behavior of engineered human heart tissue without electrodes, pacemaker wires, or chemical intervention.

The central challenge in cardiac electrophysiology is that heart cells communicate through rapidly propagating electrical waves. In a healthy heart, a precisely timed wave of depolarization sweeps across the muscle, triggering coordinated contraction. In diseased tissue, these waves can fragment, circle back on themselves, or originate from ectopic sites, producing arrhythmias that range from benign to lethal. Conventional interventions, from antiarrhythmic drugs to implanted pacemakers and ablation catheters, act on slow timescales or with coarse spatial resolution. What has been missing is a tool that can both observe and modulate cardiac electrical activity at the scale of individual cells, on millisecond timescales, within a continuous feedback loop.

The new work addresses this gap by exploiting optogenetics, a technique in which light-sensitive proteins borrowed from microbes are expressed in target cells. When blue light strikes channelrhodopsin, a light-gated ion channel embedded in the cell membrane, the channel opens and positive ions flow inward, depolarizing the cell and triggering an action potential. By genetically engineering human induced pluripotent stem cell-derived cardiomyocytes to express such opsins, researchers gain a remote, genetically specified actuator: any region of the cellular network can be electrically stimulated simply by illuminating it, with no physical contact required.

Stimulation alone, however, is only half of the control problem. The other half is sensing. The system pairs optogenetic actuation with optical voltage imaging, using fluorescent indicators whose emission changes with membrane potential. High-speed cameras capture the fluorescence of the cardiomyocyte network frame by frame, allowing the researchers to reconstruct the electrical state of the tissue in real time: which cells are resting, which are firing, and how excitation waves are propagating across the culture. This optical readout replaces the electrode arrays traditionally used to map cardiac activity, eliminating the invasiveness, wiring complexity, and spatial limitations of contact-based sensing.

The truly novel element is the holographic light engine that ties sensing and actuation together. Rather than illuminating the culture with a uniform beam or scanning a single laser spot, the researchers use a spatial light modulator to shape light into arbitrary two-dimensional patterns, projected onto the cell layer through holographic principles. A computer-generated hologram determines, pixel by pixel, where light intensity is delivered. This means the system can stimulate a single cell, a stripe of tissue, a curved wavefront mimicking the sinus node, or multiple disconnected regions simultaneously, all with subcellular spatial resolution and microsecond-scale temporal precision. The hologram can be updated faster than the dynamics of a cardiac action potential, which is essential for genuine real-time control.

Closing the loop requires software that can translate what the cameras see into what the light projector should do next. The control algorithm continuously monitors the optical voltage signals, compares the observed electrical behavior against a desired target state, and computes the illumination pattern needed to drive the network toward that state. If an excitation wave propagates too slowly, the system can deliver light pulses ahead of the wavefront to accelerate it. If an unwanted wave appears in the wrong location, the system can suppress it or redirect it. If the goal is a specific pacing frequency, the controller adjusts the timing and geometry of optical stimuli on every beat, compensating for the natural variability of biological tissue. This is the defining feature of closed-loop control: the intervention is not preprogrammed but continuously recalculated from live measurements.

The researchers demonstrated that this architecture can reliably entrain human cardiomyocyte networks to desired pacing patterns, guiding the rhythm of electrically active tissue that would otherwise beat at its own intrinsic rate. Beyond simple pacing, the holographic system’s spatial freedom enables more sophisticated interventions, such as shaping the direction and curvature of propagating waves or confining activity to defined regions of the network. Such capabilities are directly relevant to the study of arrhythmia mechanisms, where reentrant waves, spiral waves, and conduction blocks are the underlying culprits. A tool that can create, steer, and terminate such waves on demand in human-derived tissue provides an unprecedented experimental platform for arrhythmia research.

The significance for drug development and precision medicine is considerable. Human induced pluripotent stem cell-derived cardiomyocytes already allow pharmaceutical researchers to test compounds on human heart cells rather than animal tissue, but standard assays capture only bulk behavior, such as average beat rate or field potential duration. A closed-loop optical system adds an active dimension: it can probe how a tissue responds to perturbation, measure its vulnerability to arrhythmia induction, and quantify the effects of drugs on conduction velocity, refractory periods, and wave dynamics under precisely controlled stimulation conditions. In principle, patient-specific cell lines could be engineered with opsins and screened not just for passive responses but for behavior under stress, revealing proarrhythmic risks that conventional tests miss.

Looking further ahead, the all-optical nature of the approach suggests possibilities beyond the laboratory dish. Because neither sensing nor actuation requires physical contact, the conceptual framework is compatible with future cardiac therapies in which light delivered through optical fibers or implanted micro-LEDs could pace or resynchronize heart tissue in a feedback-controlled manner, guided by optical or electrical sensors. Such light-based pacemakers could adapt their stimulation pattern beat by beat, something conventional devices, which deliver fixed electrical pulses on fixed schedules, cannot do. Significant hurdles remain before any clinical translation, including delivering opsins safely to adult human myocardium, achieving sufficient light penetration in thick tissue, and ensuring long-term stability of both the genetic and optical components. The current study is confined to engineered cell networks in vitro, and the authors’ achievement should be understood as a foundational demonstration of control methodology rather than a therapy.

Even within that scope, the work marks a conceptual milestone. It shows that a living, electrically excitable human tissue can be observed, modeled, and steered in real time by a machine that touches nothing, intervening only through shaped light. The convergence of optogenetics, holographic projection, fast fluorescence imaging, and feedback control points toward a broader paradigm in synthetic biology and bioelectronic medicine: organs and organoids treated not as passive specimens but as dynamic systems that can be regulated the way engineers regulate any other process. For cardiac science, where rhythm is everything, the ability to write rhythm into human heart tissue with light, and to correct it when it goes wrong, may reshape how arrhythmias are studied, how drugs are validated, and, eventually, how failing electrical systems in the heart are repaired.

Subject of Research: All-optical closed-loop control of human cardiomyocyte networks using holographic optogenetics

Article Title: All-optical closed-loop control of human cardiomyocyte networks exploiting holographic optogenetics

Article References: Wendland, R., Schmieder, F., Sikandar, M. A., Knüppel, F. P., Zimmermann, W.-H., Bergmann, O., Büttner, L., & Czarske, J. W. (2026). All-optical closed-loop control of human cardiomyocyte networks exploiting holographic optogenetics. Communications Engineering, 5(1), Article 159. https://doi.org/10.1038/s44172-026-00779-1

Image Credits: AI Generated

DOI: 10.1038/s44172-026-00779-1

Keywords: holographic optogenetics, cardiomyocytes, closed-loop control, cardiac electrophysiology, optical voltage imaging, arrhythmia, induced pluripotent stem cells, channelrhodopsin, spatial light modulator, cardiac tissue engineering, bioelectronic medicine, optogenetic pacing